Nilotinib: Optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib

Ronan Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Jennifer Carew, Francis J. Giles

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Nilotinib: Optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds